← Back to catalogue

Zyderm Collagen Implant (Zyderm CI)

FDA PMA

Class III (US FDA PMA)

PMA P800022

by Allergan

Identity

Trade Name
ZYDERM COLLAGEN IMPLANT (ZYDERM CI) FDA PMA
Generic Name
Implant, dermal, for aesthetic use FDA PMA

Identifiers

PMA Number
P800022 FDA PMA
FDA Product Code
LMH FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
General, Plastic Surgery FDA PMA
FDA Decision
APPR Approved FDA PMA
PMA Supplement
S005 FDA PMA

The Zyderm Collagen Implant (Zyderm CI) is a dermal implant classified as an Implant, Dermal, for Aesthetic Use, designed for soft tissue augmentation. It is composed of bovine-derived collagen, intended to restore volume and contour to facial areas affected by aging or trauma. This device is intended for subcutaneous or intradermal placement to improve skin texture and reduce the appearance of wrinkles.

The Zyderm CI is supplied as a sterile, single-use product and is administered by a healthcare professional in an outpatient or clinical setting. It requires refrigeration prior to use and must be handled with sterile techniques. Approved under an FDA Premarket Approval (PMA), this device adheres to strict regulatory standards for dermal implants. Multiple registration numbers and product codes (e.g., LMH, P800022) identify its authorized variants and compliance status.

Frequently asked questions

What types of facial areas can the Zyderm Collagen Implant be used to improve, and how is it administered?

The Zyderm Collagen Implant is designed for soft tissue augmentation in facial areas affected by aging or trauma, such as reducing wrinkles or restoring volume. It is administered by a healthcare professional through subcutaneous (under the skin) or intradermal (within the skin) placement. The procedure is typically performed in an outpatient or clinical setting, requiring sterile techniques during administration.

Is the Zyderm Collagen Implant intended for reuse, and what storage conditions are required before use?

The Zyderm Collagen Implant is a single-use product, meaning it is not intended for reuse after one administration. Before use, it must be stored under refrigeration to maintain its sterility and efficacy. Always handle it with sterile techniques to prevent contamination.

What regulatory pathway was followed for the approval of the Zyderm Collagen Implant, and what does this mean for its use?

The Zyderm Collagen Implant was approved through the FDA’s Premarket Approval (PMA) process, which is the strictest regulatory pathway for Class III medical devices. This approval ensures the device meets rigorous safety and effectiveness standards for dermal implants intended for aesthetic use, such as soft tissue augmentation and wrinkle reduction.

Are there multiple variants or sizes of the Zyderm Collagen Implant, and how can I verify its regulatory compliance?

Yes, the Zyderm Collagen Implant comes in multiple variants, each identified by unique registration numbers (e.g., 1000118068, 3007093114) and product codes (e.g., LMH). To verify its regulatory compliance, check the registration numbers or product codes listed on the packaging against the FDA’s OpenFDA database or the manufacturer’s documentation, as these confirm its authorized status under the PMA pathway.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Allergan

Sources (1)

  • FDA PMA P800022 24 fields · synced Sep 18, 2026